Stéphane Bancel hospital covid-19 vaccine Stéphane Bancel

Moderna requests FDA grant priority review to its COVID-19 vaccine

Reading now: 723
www.fox29.com

CAMBRIDGE, Mass. - Moderna has passed a major milestone on its path to getting its COVID-19 vaccine fully approved by the U.S.

Food and Drug Administration.The pharmaceutical company announced Wednesday that it completed the rolling submission process for its Biologics License Application.

The BLA, which Moderna began on June 1, involves submitting nonclinical and clinical data to support the licensure of the COVID-19 vaccine.Now that it’s complete, Moderna has asked the FDA for priority review.

Once granted, that would allow the FDA to take action within a six-month window, rather than the typical 10-month time frame.In a news release, Stéphane Bancel, Chief Executive Officer of Moderna, said the company began its BLA process in June.

Read more on fox29.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA